Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Bradmer Pharma ends Neuradiab license agreement for glioblastoma multiforme

April 8, 2011

DSP and BBI sign option license agreement for anticancer drug

April 8, 2011

OBT to use BioWa's Potelligent technology for cancer programs

April 8, 2011

Novartis to sell global rights for Elidel to Meda

April 8, 2011

Optimer and Cubist Pharma to copromote Dificid for Clostridium difficile infection

April 8, 2011

PRISM and Eisai collaborate on PRI-724

April 8, 2011

Millenium Pharma and Sunesis Pharma enter agreement for kinase inhibitors in oncology

April 8, 2011

Sangamo and CHDI Foundation join to develop ZFP therapy for Huntington's disease

April 8, 2011

Celgene and ProMetic Life Sciences enter agreement for protein technologies

April 6, 2011

Aragen Bioscience receives NIAID subcontracts to develop mAbs for infectious diseases

April 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...